Kiadis Pharma Granted U.S. Patent for its Blood Cancer Treatment ATIR

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that it has received a Notice of Allowance for its U.S. Patent Application No.

http://www.biospace.com/news_story.aspx?StoryID=285382&full=1